This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When asked what factors contribute to rising health care costs in America, most consumers cite the cost of prescriptiondrugs. Taken together, these two data points demonstrate the potent political import of prescriptiondrugprices as the U.S. “The cost of hospital services has been exploding.
That’s a summary of the demand side of the trends on the health economy which serve up huge challenges for legacy health care stakeholders: hospitals and health systems, health plans, pharmaceutical and medical tech companies, and clinicians. That level of service and price satisfaction builds health consumers’ loyalty and trust.
2017 reversed advancements in health insurance coverage increases since the advent of the Affordable Care Act, and for the first time since 2014 no states’ uninsured rates fell. And there’s very little bidding on drugs.” uninsurance rate rose to 12.2% by the fourth quarter of 2017, up 1.3
Total patient OOP costs in 2018 reached $61 billion, up $2 bn from 2017, and $5 bn from 2014. When it comes to OOP costs and patient cost exposure, there’s a direct relationship between level of cost and level of prescription abandonment. For people enrolled in Medicare Part D, 20% faced over $500 in OOP costs.
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content